REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot168810.32687/1561-5936-2024-28-1-10-15Original ArticleProspects for development of the domestic hemostatic drugs market based on analysis of B02BC group salesKozhevnikovaVera A.vera.kozhevnikova@spcpu.ruGrishinaMaria G.maria.grishina@pharminnotech.comSt. Petersburg State Chemical-Pharmaceutical University, St. Petersburg, Russia151220241101515102025Copyright © 2024,2024The article presents the results of the analysis of sales dynamics of hemostatic drugs in the Russian pharmaceutical market, including drugs of the «local hemostatics» group. Moreover, the structure of the Russian market in the segment of local hemostatics is analyzed.Russian pharmaceutical marketsales dynamicsdrugs of group B02local hemostaticsbleedingdrugsроссийский фармацевтический рынокдинамика продажпрепараты группы В02местные гемостатикикровотечениелекарственные препараты[Grishina M. G., Kabachevskaya E. A., Kovalenko A. V., Halimova A. A. The Russian pharmaceutical products market: the prism of development in the terms of the existing problems of the present. Modern Economy Success. 2023;(2):129—134.]